Key Drivers
- Negative Equity
- Cash Flow
- Debt Burden
AIAI Summary
BHC now looks less like a broken turnaround and more like a cash-generating but highly leveraged deleveraging story, where sustained operating growth and free cash flow must continue to chip away at the $20.85B debt load or any pricing pressure/impairment could quickly swamp the thin equity cushion.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Negative Equity
- •Cash Flow
- •Debt Burden
BHC still generates solid cash flow and has a low sales-based valuation, but collapsing quarterly profitability, heavy debt, and a deeply negative equity base make the balance sheet and earnings outlook highly risky.
Price Behavior
Key Price Behavior Insights:
- •Lower highs
- •Nearby support
- •Failed rebound
Over the last month, BHC is still trending lower, with support near $5.29/$5.37–$5.41 but resistance at $5.65–$5.75 capping rebounds.
Rebound to $5.75 quickly faded, signaling weak momentum
Sentiment & News
Key News Insights:
- •Adjusted growth
- •Guidance reaffirmed
- •Weak demand
Bausch Health reported strong adjusted Q1 growth and reaffirmed full-year guidance, but a large goodwill impairment and weak underlying demand kept the overall picture mixed.
The news is modestly positive for near-term sentiment due to better adjusted performance and steady guidance, but leverage and volume weakness still limit the stock's upside
Similar Companies in Healthcare
Other companies in the same sector with AI ratings